Tag: pancreatic cancer
OncoSil Medical announce first patient treated in PANCOSIL trial
OncoSil Medical, a medical device company focused on localised treatments for patients with locally advanced pancreatic cancer (LAPC) announces the first patient has been...
Intra-arterial approach to locally advanced pancreatic cancer
The use of catheter-based localised delivery of drugs for treatment of cancer patients has proven to be effective and provides the benefit of reduced...
Interventional News’ top 10 most popular stories of January 2023
Interventional News’ most popular stories in the opening month of 2023 included news of first enrolments in clinical studies of peripheral arterial disease (PAD)...
Pancreatic cancer patients in Ukraine treated with tumour-specific electroporation continue to...
A team of specialists at Ulis Hospital (Ulis, Ukraine) has recently reported that the quality-of-life of the two pancreatic cancer patients treated with tumour-specific...
TriSalus presents preclinical data on proprietary infusion technology at SIR 2022
TriSalus’ clinical leadership team presented new preclinical data at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting (11–16 June, Boston, USA). The...
First patient enrolled in PERIO-02 trial of SD-101 delivery via pressure-enabled...
TriSalus Life Sciences announced the enrolment of the first patient in its Pressure-Enabled Regional Immuno-Oncology (PERIO-02) clinical study in a press release.
The trial is...
Y90 radioembolization shows promise in treating metastatic pancreatic cancer
Encouraging results from Y90 (yttrium-90) radioembolization of pancreatic cancer support a possible role for it in the management of the disease, with initial small...
Early data finds image-guided ablation “feasible and well tolerated” for oligometastatic...
A retrospective review of single-institution experience, published in July in the Journal of Vascular and Interventional Radiology (JVIR), suggests that percutaneous image-guided ablation is...
Identification of pancreatic cancer pathway could broach new era of effective...
Pancreatic Cancer Action Network (PanCAN) grantee George Miller, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department...
